TY  - JOUR
AU  - Moreno Márquez, Carolina
AU  - Fernández Álvarez, Paula
AU  - Valdés Delgado, Teresa
AU  - Castro Laria, Luisa
AU  - Argüelles Arias, Federico
AU  - Caunedo Álvarez, Ángel
AU  - Gómez Rodríguez, Blas José
PY  - 2022
DO  - 10.17235/reed.2021.7931/2021
SN  - 1130-0108
UR  - http://hdl.handle.net/10668/21704
T2  - Revista espanola de enfermedades digestivas
AB  - the primary goal of this study was to compare gastrointestinal symptom reduction in patients on bismuth-containing quadruple eradication therapy supplemented with Lactobacillus reuteri strains (DSM 17938 and ATCC PTA 6475) or placebo. this was a...
LA  - en
KW  - Abdominal Pain
KW  - Anti-Bacterial Agents
KW  - Bismuth
KW  - Drug Therapy, Combination
KW  - Helicobacter Infections
KW  - Helicobacter pylori
KW  - Humans
KW  - Limosilactobacillus reuteri
KW  - Metronidazole
KW  - Probiotics
KW  - Treatment Outcome
TI  - Randomized, double-blind, placebo-controlled clinical trial on the usefulness of probiotic Lactobacillus reuteri in bismuth-containing quadruple eradication therapy for infection with Helicobacter pylori.
TY  - research article
VL  - 114
ER  -